Search This Site:
Clinical Commissioning Groups Logo

Prescribing Information & Guidance

High strength, fixed combination and biosimilar insulin products: minimising the risk of medication error – Safety Reminder

Guideline added to website on: 09/06/20
Last modified on: 09/10/20
CCG: |
Section:
Category:
Tags: high, insulin, strength

Tagged with: | |
Scroll to Top